An announcement from Remegen (09995) indicates that a batch of restricted shares from its initial public offering will become tradable. The shares, totaling 193 million, were allocated through an offline placement and are set to be released for trading on July 1, 2026.

According to the filing, the total number of shares entering the market is 193 million. However, the company notes that due to its cash dividend distribution not meeting specific regulatory requirements set by the Shanghai Stock Exchange, the shareholders eligible for this lock-up release are prohibited from selling their A-shares through either centralized bidding or block trades on the exchange.